16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
E2A50a
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
3K54

Suli Pharmaceutical Technology Jiangyin Co., Ltd.

  • Suli Pharma Jiangying production site
About Suli Pharmaceutical Technology Jiangyin Co., Ltd.

Suli Pharmaceutical Technology Jiangyin Co., Ltd., a wholly-owned subsidiary of Suli Group, was established in 2009,consisting of Suli Pharma Shanghai R&D Center, Suli Pharma Jiangyin Production Site, and Dalian Yongda-Suli Pharma. Relying on the company's technical advantages, sufficient production capability and capacity, lean management on production, safety and high standard GMP quality management, Suli Pharma is committed to providing our worldwide clients the APIs/intermediates and CMO/CDMO services with stable quality, competitive price and best services.

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • Founded:
    2009
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Contact info

Products from Suli Pharmaceutical Technology Jiangyin Co., Ltd. (14)